Key result
Non-contact mapping guided cardiac resynchronization therapy improved ejection fraction from 23% to 33% and NYHA status from III to II at 6 months in a patient with a failing systemic right ventricle.
Why the study?
Does non-contact mapping guided cardiac resynchronization therapy improve systemic right ventricular function in a patient with a failing systemic right ventricle post-Mustard correction?
Case Report (n=1)
Does non-contact mapping guided cardiac resynchronization therapy improve systemic right ventricular function in a patient with a failing systemic right ventricle post-Mustard correction?
Non-contact mapping guided CRT improved systemic right ventricular function and clinical status in a patient with a failing systemic right ventricle post-Mustard correction.
Answers are grounded in this paper and cite their sources.
May warrant individualized consideration in complex congenital cases; leaves open efficacy and safety in systemic right ventricles.
AIMS: Progressive systemic right ventricular (sRV) dysfunction, atrial and ventricular arrhythmias and sudden cardiac death are well-recognized late sequelae of atrial redirection surgery in which the right ventricle is left connected to the systemic circulation. Although cardiac resynchronization therapy (CRT) poses an attractive therapeutic option, little is known about indications, patient selection, and technical aspects of best lead placement. METHODS AND RESULTS: We undertook CRT in a 27-year-old female patient post-Mustard correction for d-transposition (d-TGA) with New York Heart Association (NYHA) grade III disability with QRS duration measuring 130 ms. There was also echocardiographic (TTE) evidence of severe sRV dysfunction. Non-contact mapping (NCM) was used to define sites of late activation within the sRV and the acute intra-arterial blood pressure (BP) response was assessed during implantation of a 4 french (F) lead onto the endocardial surface of the sRV. At 4 weeks post-implant sRV lateral wall motion had improved and the ejection fraction (EF) rose from 23 to 33%. The patient has been successfully anticoagulated and improved to NYHA II status after 6 months. CONCLUSION: The use of NCM proved safe and effective and provided a qualitative assessment of electrical viability of the sRV complimenting the measurement of mechanical function provided by TTE. The favourable clinical response in the above case justifies a prospective evaluation of this strategy.
No takes yet. Share an insight, caveat, or question.
Michael et al. (2007) conducted a case report in Systemic right ventricular dysfunction post-Mustard correction for d-TGA (n=1). Non-contact mapping guided cardiac resynchronization therapy was evaluated on Ejection fraction and NYHA status. Non-contact mapping guided cardiac resynchronization therapy improved ejection fraction from 23% to 33% and NYHA status from III to II at 6 months in a patient with a failing systemic right ventricle.
Synapse has enriched 10 related papers. Consider them for comparative context: